XML 47 R30.htm IDEA: XBRL DOCUMENT v3.25.0.1
Common Stock (Tables)
12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Aggregate Warrants

As of December 31, 2024, the following aggregate warrants to purchase shares of the Company’s common stock were issued and outstanding:

 

Issue Date

 

Expiration Date

 

Exercise Price per Share

 

 

Number of Shares subject to Outstanding Warrants

 

July 11, 2024

 

None

 

$

0.0001

 

 

 

285,715

 

October 27, 2023

 

None

 

$

0.0001

 

 

 

319,150

 

April 27, 2023

 

None

 

$

0.0001

 

 

270,270(1)

 

 

(1) In September 2024, 1,750,000 shares of common stock subject to outstanding pre-funded warrants were cashless exercised and 1,749,993 shares of common stock were issued.

Schedule of Number of Common Stock Reserved for Future Issuance

The Company had reserved common stock for future issuance as follows:

 

 

As of December 31,

 

 

 

2024

 

 

2023

 

Exercise of outstanding options under the 2015, 2019 and 2023 Plans

 

 

7,737,595

 

 

 

6,269,975

 

Shares available for grant under the 2019 Plan

 

 

1,910,589

 

 

 

964,622

 

Shares available for grant under the 2023 Inducement Plan

 

 

593,592

 

 

 

524,300

 

Shares available under the Employee Stock Purchase Plan

 

 

1,911,011

 

 

 

1,317,974

 

Pre-funded warrants issued and outstanding

 

 

875,135

 

 

 

2,339,420

 

Total

 

 

13,027,922

 

 

 

11,416,291